Prosecution Insights
Prosecution Insights
43 pending office actions • 28 art units • 41 examiners • 0 of 43 (0%) have an AI response strategy ready • 33 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 6 (14%) |
| §103 only | 10 (23%) |
| §102 only | 3 (7%) |
| §112 only | 1 (2%) |
| Double-patenting only | 2 (5%) |
| Double-patenting + other | 6 (14%) |
| Multi-statute (no §101) | 14 (33%) |
| No statute on record | 1 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, KHOA NHAT | 2 | 42.0% | +58.8% |
| CHANG, KYUNG SOOK | 2 | 60.4% | +41.1% |
| MERCIER, MELISSA S | 1 | 72.1% | +6.1% |
| LABRANCHE, BROOKE N | 1 | 73.0% | +15.0% |
| ANTHOPOLOS, PETER | 1 | 57.2% | +59.0% |
| PATEL, NIDHI NIRAJ | 1 | 54.2% | +46.1% |
| MCCOLLUM, ANDREA K | 1 | 60.9% | +32.2% |
| SONG, HOON K | 1 | 86.2% | +8.4% |
| ARON, KIMBERLY A | 1 | 54.7% | +34.9% |
| KNIGHT, TERESA E | 1 | 65.7% | +48.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18563276 | SYSTEMS AND METHODS FOR PATIENT TRACKING DURING RADIATION THERAPY | SONG, HOON K | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918479 | TARGETING ABCB5 IN GLIOBLASTOMA MULTIFORME | AEDER, SEAN E | 43d overdue |
| 18477081 | SYSTEM, METHODS, AND STORAGE MEDIUMS FOR RELIABLE URETEROSCOPES AND/OR FOR IMAGING | BURKE, TIONNA M | 36d overdue |
| 18494528 | COMPOSITIONS AND METHODS FOR CHARACTERIZING POLYNUCLEOTIDE SEQUENCE ALTERATIONS | TURPIN, ZACHARY MARK | 4d overdue |
| 17738843 | EX VIVO TISSUE EXPLANT AND GRAFT PLATFORM AND USES THEREOF | TRAN, KHOA NHAT | 4d overdue |
| 18313931 | AUTOMATED DETECTION AND MANAGEMENT OF VAVLULAR HEART DISEASE USING MACHINE LEARNING | LAGOY, KYRA RAND | 12d |
| 17739803 | SYSTEMS, METHODS, AND BIOMATERIALS FOR RADIATION THERAPY | DICKINSON, PAUL W | 56d |
| 18777479 | READILY SOLUBLE AND THERMOSTABLE GLUCAGON FORMULATIONS AND DELIVERY FOR MINI-DOSING AND CLOSED-LOOP PROPHYLACTIC TREATMENT OF HYPOGLYCEMIA | PATEL, NIDHI NIRAJ | — |
| 18530114 | STING LEVELS AS A BIOMARKER FOR CANCER IMMUNOTHERAPY | MCCOLLUM, ANDREA K | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17738843 | EX VIVO TISSUE EXPLANT AND GRAFT PLATFORM AND USES THEREOF | TRAN, KHOA NHAT | 4d overdue |
| 18840246 | MOUNTING DEVICE OF A STEREOTACTIC SYSTEM AND METHOD OF USE THEREOF | LABRANCHE, BROOKE N | — |
| 18799051 | Elastic Biopolymer and Use as a Tissue Adhesive | ANTHOPOLOS, PETER | — |
| 18777479 | READILY SOLUBLE AND THERMOSTABLE GLUCAGON FORMULATIONS AND DELIVERY FOR MINI-DOSING AND CLOSED-LOOP PROPHYLACTIC TREATMENT OF HYPOGLYCEMIA | PATEL, NIDHI NIRAJ | — |
| 18633827 | METHODS AND COMPOSITIONS FOR DELIVERY OF IMMUNOTHERAPY AGENTS ACROSS THE BLOOD-BRAIN BARRIER TO TREAT BRAIN CANCER | TRAN, KHOA NHAT | — |
| 18596376 | SYNTHETIC TISSUE BARRIERS AND USES THEREOF | CHANG, KYUNG SOOK | — |
| 18530114 | STING LEVELS AS A BIOMARKER FOR CANCER IMMUNOTHERAPY | MCCOLLUM, ANDREA K | — |
| 18507432 | NEUROPROTECTIVE MOLECULES AND METHODS OF TREATING NEUROLOGICAL DISORDERS AND INDUCING STRESS GRANULES | ARON, KIMBERLY A | — |
| Art Unit | Apps |
|---|---|
| 3791 | 3 |
| 3783 | 3 |
| 3771 | 2 |
| 1613 | 2 |
| 3795 | 2 |
| 1641 | 2 |
| 1632 | 2 |
| 1743 | 1 |
| 2884 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18869925 | MOLECULARLY CLEAVABLE BIOINK FORMULATION | MERCIER, MELISSA S | 1743 | §102 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18840246 | MOUNTING DEVICE OF A STEREOTACTIC SYSTEM AND METHOD OF USE THEREOF | LABRANCHE, BROOKE N | 3771 | §103 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18799051 | Elastic Biopolymer and Use as a Tissue Adhesive | ANTHOPOLOS, PETER | — | §103§112DP | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18777479 | READILY SOLUBLE AND THERMOSTABLE GLUCAGON FORMULATIONS AND DELIVERY FOR MINI-DOSING AND CLOSED-LOOP PROPHYLACTIC TREATMENT OF HYPOGLYCEMIA | PATEL, NIDHI NIRAJ | 3791 | §102§103§112 | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18633827 | METHODS AND COMPOSITIONS FOR DELIVERY OF IMMUNOTHERAPY AGENTS ACROSS THE BLOOD-BRAIN BARRIER TO TREAT BRAIN CANCER | TRAN, KHOA NHAT | — | §112DP | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18596376 | SYNTHETIC TISSUE BARRIERS AND USES THEREOF | CHANG, KYUNG SOOK | 1613 | §103§112DP | Non-Final OA | — | Pending | Mar 05, 2024 |
| 18530114 | STING LEVELS AS A BIOMARKER FOR CANCER IMMUNOTHERAPY | MCCOLLUM, ANDREA K | — | §101§112 | Non-Final OA | — | Pending | Dec 05, 2023 |
| 18563276 | SYSTEMS AND METHODS FOR PATIENT TRACKING DURING RADIATION THERAPY | SONG, HOON K | 2884 | §103 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18507432 | NEUROPROTECTIVE MOLECULES AND METHODS OF TREATING NEUROLOGICAL DISORDERS AND INDUCING STRESS GRANULES | ARON, KIMBERLY A | 1633 | §112DP | Non-Final OA | — | Pending | Nov 13, 2023 |
| 18506291 | CRYOBIOPRINTING FOR TISSUE FABRICATION AND STORAGE | KNIGHT, TERESA E | 1634 | §102§103 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18494528 | COMPOSITIONS AND METHODS FOR CHARACTERIZING POLYNUCLEOTIDE SEQUENCE ALTERATIONS | TURPIN, ZACHARY MARK | 1682 | §103§112 | Non-Final OA | 4d overdue | Pending | Oct 25, 2023 |
| 18477081 | SYSTEM, METHODS, AND STORAGE MEDIUMS FOR RELIABLE URETEROSCOPES AND/OR FOR IMAGING | BURKE, TIONNA M | 2178 | §102§103 | Final Rejection | 36d overdue | Pending | Sep 28, 2023 |
| 18345981 | FUNCTIONAL UTERINE MANIPULATOR | BACHMAN, LINDSEY MICHELE | 3771 | DP | Final Rejection | 73d overdue | Pending | Jun 30, 2023 |
| 18269168 | COMPOSITIONS AND METHODS RELATED TO BICYCLO[2.2.1] HEPTANAMINE-CONTAINING COMPOUNDS | OH, TAYLOR V | 1625 | §102§103 | Final Rejection | — | Pending | Jun 22, 2023 |
| 18039777 | SPECTROMETRY SYSTEMS, METHODS, AND APPLICATIONS | EPPERT, LUCY CLARE | 3791 | §103 | Final Rejection | — | Pending | Jun 01, 2023 |
| 18035969 | METAL-ORGANIC FRAMEWORK MEDIATED MACROMOLECULE DELIVERY SYSTEM | ALAM, AYAAN A | 1611 | §103§112 | Non-Final OA | — | Pending | May 09, 2023 |
| 18027261 | ROBOTIC ARTIFICIAL INTELLIGENCE NASAL/ORAL/RECTAL ENTERIC TUBE | ABBASI, ABDUL HADI | 3795 | §103 | Final Rejection | — | Pending | Mar 20, 2023 |
| 18026442 | SYSTEM AND METHOD FOR VIRUS DETECTION USING NANOPARTICLES AND A NEURAL NETWORK ENABLED MOBILE DEVICE | THOMPSON, MILANA KAYE | — | §103 | Non-Final OA | — | Pending | Mar 15, 2023 |
| 18166997 | CONTINUUM ROBOT APPARATUSES, METHODS, AND STORAGE MEDIUMS | GHIMIRE, SHANKAR RAJ | 3795 | §102§103 | Non-Final OA | — | Pending | Feb 09, 2023 |
| 18088039 | SYSTEMS AND METHODS FOR DETERMINING CARDIAC OUTPUT | TU, AURELIE H | 3791 | §101§102§103§112 | Final Rejection | — | Pending | Dec 23, 2022 |
| 17928452 | USE OF MICROVESICLE SIGNATURE FOR THE DIAGNOSIS AND TREATMENT OF KIDNEY TRANSPLANT REJECTION | YU, TIAN NMN | 1681 | §101§103DPOther | Non-Final OA | — | Pending | Nov 29, 2022 |
| 17918479 | TARGETING ABCB5 IN GLIOBLASTOMA MULTIFORME | AEDER, SEAN E | 1642 | §103§112 | Non-Final OA | 43d overdue | Pending | Oct 12, 2022 |
| 17913509 | TNFAIP3 AS A BIOMARKER FOR AUTOIMMUNE DISEASES | JOHNSON, TIRONE DEREK | 1675 | §103§112 | Non-Final OA | — | Pending | Sep 22, 2022 |
| 17907781 | SELECTIVE MODULATION OF TRANSFORMING GROWTH FACTOR BETA SUPERFAMILY SIGNALING VIA MULTI-SPECIFIC ANTIBODIES | BRISTOL, LYNN ANNE | 1643 | §112 | Non-Final OA | 53d | Pending | Aug 29, 2022 |
| 17878458 | SYSTEM, ASSAY AND METHOD FOR PARTITIONING PROTEINS | FLINDERS, JEREMY C | 1684 | §102§103 | Non-Final OA | — | Pending | Aug 01, 2022 |
| 17851889 | SYSTEM AND METHOD FOR RESISTANCE-DEPENDENT, SELF-REGULATED MEDICAL PENETRATION | DARB, HAMZA A. | 3783 | §103 | Non-Final OA | — | Pending | Jun 28, 2022 |
| 17784598 | SYNTHETIC TISSUE BARRIERS AND USES THEREOF | CHANG, KYUNG SOOK | 1613 | DP | Final Rejection | — | Pending | Jun 10, 2022 |
| 17836972 | RESIDENCE STRUCTURES AND RELATED METHODS | VANHORN, ABIGAIL LOUISE | 1636 | §103§112DP | Final Rejection | — | Pending | Jun 09, 2022 |
| 17780407 | COMPOSITIONS AND METHODS FOR EPITOPE SCANNING | WEN, SHARON X | 1641 | §103 | Non-Final OA | — | Pending | May 26, 2022 |
| 17776828 | CODON OPTIMIZED NEW GENERATION REGULATABLE FUSOGENIC ONCOLYTIC HERPES SIMPLEX VIRUS TYPE 1 VIRUS AND METHODS OF USE | GILL, RACHEL B | 1641 | §101§112DP | Non-Final OA | — | Pending | May 13, 2022 |
| 17739803 | SYSTEMS, METHODS, AND BIOMATERIALS FOR RADIATION THERAPY | DICKINSON, PAUL W | 1618 | §102§103§112Other | Non-Final OA | 56d | Pending | May 09, 2022 |
| 17738843 | EX VIVO TISSUE EXPLANT AND GRAFT PLATFORM AND USES THEREOF | TRAN, KHOA NHAT | 1632 | §101§102§103 | Non-Final OA | 4d overdue | Pending | May 06, 2022 |
| 17637145 | MEDICAL MICRODEVICE ANCHORING APPARATUS, INSTALLATION AND RETRIEVAL TOOLS, AND METHODS OF USING SAME | MEDWAY, SCOTT J | 3783 | §102 | Non-Final OA | 33d | Pending | Feb 22, 2022 |
| 17625425 | LONGEVITY SIGNATURES AND THEIR APPLICATIONS | MCMILLIAN, KARA RENITA | 1623 | §102§112 | Final Rejection | — | Pending | Jan 07, 2022 |
| 17570104 | FUSION PROTEIN NANODISK COMPOSITIONS AND METHODS OF TREATMENT | MARTIN, RACHEL E | 1657 | §103 | Non-Final OA | 81d overdue | Pending | Jan 06, 2022 |
| 17558402 | Polyphenols as Modulators of Platelet Function | LEE, CHIHYI NMN | 1628 | §102§103§112DP | Non-Final OA | — | Pending | Dec 21, 2021 |
| 17339889 | SYSTEMS AND METHODS FOR ANALYTE DETECTION USING ELECTROMAGNETICALLY INDUCED RESONANCE | DUNN, MCKENZIE A | 1678 | §103 | Final Rejection | 26d | Pending | Jun 04, 2021 |
| 17293968 | ACTUATING COMPONENTS AND RELATED METHODS | SWANSON, LEAH JENNINGS | 3783 | §103§112 | Final Rejection | — | Pending | May 14, 2021 |
| 17257923 | METHODS AND MATERIALS FOR IMPROVING TRANSPLANT OUTCOMES | SCHUBERG, LAURA J | 1631 | §102 | Non-Final OA | 49d | Pending | Jan 05, 2021 |
| 16992362 | THREE-DIMENSIONAL DIFFERENTIATION OF EPIBLAST SPHEROIDS TO KIDNEY ORGANOIDS MODELS STAGE-SPECIFIC EPITHELIAL PHYSIOLOGY, MORPHOGENESIS, AND DISEASE | MOLOYE, TITILAYO | 1632 | Other | Final Rejection | 22d | Pending | Aug 13, 2020 |
| 18911790 | MEDICAL INFORMATION PROCESSING APPARATUS, MEDICAL INFORMATION PROCESSING METHOD, AND COMPUTER-READABLE STORAGE MEDIUM | LIN, JESSICA YIFANG | — | §102§103 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18911571 | MEDICAL INFORMATION PROCESSING APPARATUS AND COMPUTER-READABLE STORAGE MEDIUM | YANG, JIANXUN | — | §103 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18313931 | AUTOMATED DETECTION AND MANAGEMENT OF VAVLULAR HEART DISEASE USING MACHINE LEARNING | LAGOY, KYRA RAND | 3685 | §101§103 | Final Rejection | 12d | Pending | May 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial